Cannabis News

ABcann Global Corporation Announces $70 Million Bought Deal Financing

2018-01-29

ABcann Global Corporation (TSXV:ABCN) announced today that it has entered into an agreement with Canaccord Genuity Corp. and Eight Capital, on their own behalf and on behalf of a syndicate of underwriters, pursuant to which the Underwriters will purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of: (i) 11,500,000 units of the Company at a price of $3.50 per Unit for aggregate gross proceeds of $40,250,000; and (ii) 30,000 unsecured convertible debentures of the Company at a price of $1,000 per Convertible Debenture for aggregate gross proceeds of $30,000,000.

Invictus MD Jumpstarts Revenue Stream With Sale of First 120 kg of Flower to Canopy Growth Corporation; Signs Definitive Agreement to Increase Ownership of AB Laboratories in Ontario from 33.3% to 50%

2018-01-26

INVICTUS MD STRATEGIES CORP. (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce the sale of its first 120 kg of dried flower from AB Laboratories Inc., the licensed production facility under the Access to Cannabis for Medical Purposes Regulations, near Hamilton to Canopy Growth Corporation (TSX:WEED)

Aurora Cannabis and CanniMed Therapeutics Agree to Terms on Friendly Transaction

2018-01-24

Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CanniMed Therapeutics Inc. (TSX: CMED) announce today that they have entered into a support agreement whereby the Board of Directors and the Special Committee of the CanniMed Board have agreed to support a new offer made by Aurora for the acquisition of all of the issued and outstanding shares of CanniMed not owned by Aurora.

MedMen Prepares to Go Public in Canada

2018-01-24

Multi-state cannabis operator MedMen plans to go public in Canada early in the second quarter of 2018, listing on the Canadian Securities Exchange (CSE).

Maricann Group Announces Proposed Acquisition

2018-01-24

Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI), is pleased to announce a non-binding term sheet for the proposed acquisition of all outstanding shares of Haxxon AG for an aggregate purchase price of CHF 8,000,000, of which CHF 2,000,000 will be payable in cash and the remainder in common stock of the Company at the 20-day vwap prior to closing.

WeedMD Commences the Sale of Cannabis Oil

2018-01-23

WeedMD Inc. (TSX-V:WMD), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that it has launched the sale of medical cannabis oil to its growing registered patient base.

INMED TO PRESENT AT CANACCORD GENUITY CONFERENCE

2018-01-23

InMed Pharmaceuticals, Inc. (CSE:IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today it will present at Canaccord Genuity's 2nd Annual Cannabis Investor Day taking place at The Fairmont Waterfront Hotel in Vancouver, BC, on Wednesday, January 24, 2018.

Namaste Receives Health Canada Confirmation of Readiness

2018-01-22

Namaste Technologies Inc. (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that Health Canada’s Office of Medical Cannabis has provided the Company with a Confirmation of Readiness for a license under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) for the Company’s wholly owned subsidiary, Cannmart Inc.